@article {du Bois1328, author = {Andreas du Bois and Alexander Reuss and Eric Pujade-Lauraine and Sandro Pignata and Jonathan Ledermann and Antonio Casado and Jalid Sehouli and Mansoor Mirza and Nicoletta Colombo and Christian Marth and Els Witteveen and Jose Del Campo and Paula Calvert and Gerassimos Aravantinos and Mehmet Ali Vardar and Ate G.J. van der Zee and Jacob Korach and Cagatay Taskiran and Mathias Fehr and Ros Glasspool and Jacobus Pfisterer and David Cibula and Ignace Vergote}, title = {European Network of Gynaecological Oncological Trial Groups{\textquoteright} Requirements for Trials Between Academic Groups and Industry Partners{\textemdash}First Update 2015}, volume = {25}, number = {7}, pages = {1328--1330}, year = {2015}, doi = {10.1097/IGC.0000000000000478}, publisher = {BMJ Specialist Journals}, abstract = {Abstract The first version of ENGOT{\textquoteright}s Requirements for Trials Between Academic Groups and Industry Partners in Europe was published 2010. This first update integrates the experiences made by the ENGOT network and the cooperative group studies while performing, analyzing, and publishing -among others - three large phase III trials. Furthermore, progress in European legislation and its impact on clinical studies in Europe have been considered in this update process.}, issn = {1048-891X}, URL = {https://ijgc.bmj.com/content/25/7/1328}, eprint = {https://ijgc.bmj.com/content/25/7/1328.full.pdf}, journal = {International Journal of Gynecologic Cancer} }